Hong Kong Autumn Electronics Fair and electronicAsia attract over 61,000 buyers for sourcing, business opportunities 
Cotecna Group Acquires Energon Labs, Strengthening Global Pharmaceutical Testing Capabilities and Expanding its Presence in India 
Alkagesta Advances ESG Commitments Across Asian and European Markets Amid Record Trading Performance 
Casa Minerals Announces Closing of Second Tranche of Private Placement 
Black Spade bringing Squid Game: The Experience to Southeast Asia Healthy Extracts Enters Retail Marketplace, Launching Brain Health Products in Over 160 Natural Grocers® Stores Nationwide
Nation’s Largest Family-Operated Organic & Natural Grocer Healthy Extracts launches in over 160 Natural Grocers…
Hepion Pharmaceuticals Further Strengthens Board with Appointments of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati
EDISON, N.J., June 28, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical mid-stage…
Aleafia Health Announces Record $43.1 Million Net Revenue in 2022 15-Month Fiscal Year, Strong $8 Million Branded Cannabis Net Revenue in Q5
151% increase in branded cannabis net revenue1 to $36.8 million in 15-month fiscal year 2022…
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay…
Larimar Therapeutics Announces Oral Presentation at the Upcoming Gordon Research Conference on Mitochondria and Chloroplasts
BALA CYNWYD, Pa., June 28, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development
Advances lead optimization, first-in-human dose prediction and formulation development PRINCETON, N.J., June 28, 2022 (GLOBE…
Merakris CEO To Discuss Dermacyte® Development Program As Part of Advanced Wound Care Summit Panel in July
RESEARCH TRIANGLE PARK, N.C., June 28, 2022 (GLOBE NEWSWIRE) — About five years ago, the…
Araris Biotech AG to Present at the H.C. Wainwright Preclinical Cancer Drug Discovery Virtual Conference
ZURICH, Switzerland, June 28, 2022 (GLOBE NEWSWIRE) — Araris Biotech AG, a company pioneering a…
Panbela Announces Publication of Preclinical Data Titled: Expanded Potential of the Polyamine Analogue SBP-101 (Diethyl Dihydroxyhomospermine) as a Modulator of Polyamine Metabolism and Cancer Therapeutic
In vitro studies determined that SBP-101 reduced cellular viability across a broad range of cancer…
G1 Therapeutics Announces Addition of Jacks Lee to Board of Directors
RESEARCH TRIANGLE PARK, N.C., June 28, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Verrica Pharmaceuticals Holds Type A Meeting with FDA for VP-102 for Molluscum Contagiosum
WEST CHESTER, Pa., June 28, 2022 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA),…
Fate Therapeutics Announces Expansion of Solid Tumor Collaboration with ONO Pharmaceutical for Off-the-Shelf, iPSC-derived CAR NK and CAR T-Cell Cancer Immunotherapies
ONO to Contribute Novel Binding Domains for a Second Solid Tumor Antigen to the Collaboration…
EnGeneIC’s second generation COVID-19 vaccine protects against all variants
SYDNEY, Australia, June 28, 2022 (GLOBE NEWSWIRE) — The world’s first COVID-19 vaccine to offer…
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy
– 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity…
Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236
First-in-class, oral, RAS(ON) Inhibitor being evaluated initially in patients with cancers driven by KRASG12 mutations…
ProQR to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference
CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology…
Roivant Sciences Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2022 and Provides Business Update
Potential blockbuster VTAMA® (tapinarof) approved by FDA for the treatment of plaque psoriasis at end…
Defense Technologies International Corp. (DTII): FINRA Approves Reverse Split
Del Mar, California–(Newsfile Corp. – June 28, 2022) – Defense Technologies International Corp. (OTC Pink:…
The Ascension of Asensus in Performance-Guided Surgery
Key commercial and regulatory milestones expected during the second half of 2022 New York, New…